Epcoritamab monotherapy for relapsed or refractory large B-Cell lymphoma: 3-year follow-up from EPCORE NHL-1
Karimi, Y. H. ; Vose, J. M. ; Cheah, C. Y. ; Clausen, M. R. ; Cunningham, D. ; Farooq, U. ; Feldman, T. ; Ghesquieres, H. ; Jurczak, W. ; Linton, K. M. ... show 10 more
Karimi, Y. H.
Vose, J. M.
Cheah, C. Y.
Clausen, M. R.
Cunningham, D.
Farooq, U.
Feldman, T.
Ghesquieres, H.
Jurczak, W.
Linton, K. M.
Citations
Altmetric:
Abstract
Description
Date
2025
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Karimi YH, Vose JM, Cheah CY, Clausen MR, Cunningham D, Farooq U, et al. Epcoritamab Monotherapy for Relapsed or Refractory Large B-Cell Lymphoma: 3-Year Follow-Up From EPCORE NHL-1. British journal of haematology. 2025 APR;206. PubMed PMID: WOS:001517858300050. English.